Chester County News and Community Website
PHILADELPHIA, PA — Virion Therapeutics will present long-term clinical trial results for its experimental hepatitis B immunotherapy, VRON-0200, on November 9 at a major liver disease conference in Denver, providing …
Virion to Present Two-Year Hepatitis B Treatment Data Read More PHILADELPHIA, PA — Virion Therapeutics reported new long-term data showing its experimental hepatitis B immunotherapy, VRON-0200, produced sustained reductions in key disease markers for more than two years after a …
Virion Reports Long-Term Hepatitis B Response in Early Trial Read More PHILADELPHIA, PA — Virion Therapeutics LLC reported data showing its experimental hepatitis B immunotherapy VRON-0200 generated sustained immune responses in chronically infected patients following a single dose, the company announced …
Virion Therapeutics Reports Phase 1b Data for HBV Immunotherapy VRON-0200 Read More PHILADELPHIA, PA — Virion Therapeutics, LLC said it presented data at the 33rd Conference on Retroviruses and Opportunistic Infections in Denver showing that a single intramuscular dose of its investigational …
Virion Reports VRON-0200 Data in Chronic Hepatitis B Study Read More PHILADELPHIA, PA — Virion Therapeutics, LLC announced that new clinical data from its VRON-0200 program for chronic Hepatitis B virus (HBV) infection will be featured in an oral presentation at …
Virion Therapeutics to Present New Chronic Hepatitis B Data at AASLD Liver Meeting Read More